Maple-Brown Abbott’s MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A MR Stock Holding History

Maple-Brown Abbott’s Portfolio MR Stock Details MR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-410,881	Closed	-$11.1M	–	21
2015 Q4	$11.1M	Sell	410,881 -265,621	-39%	-$6.84M	3.78%	13
2015 Q3	$14.8M	Hold	676,502	–	–	5.59%	8
2015 Q2	$19.3M	Buy	676,502 +81,219	+14%	+$2.37M	7.39%	5
2015 Q1	$16.3M	Buy	595,283 +501,859	+537%	+$13.8M	7.28%	5
2014 Q4	$2.47M	Buy	+93,424	New	+$2.73M	1.63%	16

Other funds holding MR

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Maple-Brown Abbott's MR Position: Q1 2016 in Review

Maple-Brown Abbott sold out of MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A (MR) in Q1 2016, closing a stake of 410,881 shares — an estimated $11.1M sold.

Maple-Brown Abbott first reported a position in MR in Q4 2014 and held it in 5 quarters. The position peaked at $19.3M in Q2 2015. 2 funds tracked by Wall St. Rank hold MR as of Q1 2016.

Maple-Brown Abbott reported no remaining MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position as of Q1 2016 after selling out during the quarter.
Maple-Brown Abbott sold 410,881 MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A shares in Q1 2016, an estimated $11.1M.
Maple-Brown Abbott first reported a position in MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A in Q4 2014 and held it in 5 quarters.
Maple-Brown Abbott's MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position peaked at $19.3M in Q2 2015.
2 funds tracked by Wall St. Rank held MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A as of Q1 2016.

Based on Maple-Brown Abbott's 13F filing for Q1 2016, filed 9 Aug 2016.